Athira Pharma secures $90M in upfront financing and up to $146M in warrants to support Phase 3 development of lasofoxifene for metastatic breast cancer, co-led by Commodore Capital and Perceptive Advisors.
Amount Raised
$90 Million
Round Type
Funding Round
BothellBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Athira Pharma has announced a financing of up to $236 million, including an upfront $90 million in private placement financing. The funds will support the development of lasofoxifene for metastatic breast cancer. This financing is co-led by Commodore Capital, Perceptive Advisors, and TCGX. The company aims to achieve key clinical and regulatory milestones with this investment.
Quick answer
LeonaBio, Inc. raised $90 Million in a Funding Round round, dated December 18, 2025. Investors: Adar1, Blackstone Multi Asset Investing, Kalehua Capital, Commodore Capital, Perceptive Advisors and Tcgx. LeonaBio, Inc. is based in Bothell, Washington, United States.
- How much did LeonaBio, Inc. raise?
- LeonaBio, Inc. raised $90 Million in a Funding Round round on December 18, 2025.
- Who invested in LeonaBio, Inc?
- Adar1, Blackstone Multi Asset Investing, Kalehua Capital, Commodore Capital, Perceptive Advisors and Tcgx are named as investors in this round.
- What does LeonaBio, Inc. do?
- Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration.
- Where is LeonaBio, Inc. based and how big is it?
- LeonaBio, Inc. is based in Bothell, Washington, United States.
- Who are the decision-makers at LeonaBio, Inc?
- Fundz holds 1 contact at LeonaBio, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as LeonaBio, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $3.5M on January 14, 2026.
- Parabilis Medicines raised $305M (Series F) on January 8, 2026.
- Navega Therapeutics raised $1.3M (Seed) on January 2, 2026.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- Citius Oncology raised $18M (Funding Round) on December 9, 2025.
- Axoltis Pharma raised $21M (Series A) on December 2, 2025.
Who to call at LeonaBio, Inc., and when
A new round usually means LeonaBio, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LeonaBio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LeonaBio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LeonaBio, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LeonaBio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
LeonaBio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.